Colorado · 2020-2021
Off-label Use Of Approved Drugs To Treat COVID-19
Read HB21-1202 at the Colorado legislature →
13 registered positions on this bill · 13 state a side.
| Lobbyist or firm | For client | Position | Session |
|---|---|---|---|
| FRITTS, KELLI L | AARP | Monitoring | 2020-2021 |
| OnTheBallot Consulting | Astellas Pharma US, Inc. | Monitoring | 2020-2021 |
| 76 Group | Boehringer - Ingelheim | Monitoring | 2020-2021 |
| REES CONSULTING AND PUBLIC AFFAIRS | Centura Health | Monitoring | 2020-2021 |
| BRANDEBERRY MCKENNA PUBLIC AFFAIRS | Colorado Hospital Association | Monitoring | 2020-2021 |
| Burkhart, Amber | Colorado Hospital Association | Monitoring | 2020-2021 |
| Ewing, Joshua | Colorado Hospital Association | Monitoring | 2020-2021 |
| MULREADY, KATHERINE | Colorado Hospital Association | Monitoring | 2020-2021 |
| Mendez, Barkis and Associates | Denver Health | Opposing | 2020-2021 |
| Miles Consulting, Inc. dba Frontline Public Affairs | Denver Health Hospital Authority | Opposing | 2020-2021 |
| Williams, Alyson Brozovich | Health District of Northern Larimer County | Monitoring | 2020-2021 |
| Politicalworks, LLC | KAISER PERMANENTE | Monitoring | 2020-2021 |
| Groves, Shannon E | Kaiser Foundation Health Plan | Monitoring | 2020-2021 |
Positions are as filed. A lobbyist may file more than once as a position changes.